Gregory F. Liposky

Gregory F. Liposky discloses dealings in GTC Biotherapeutics Inc to SEC (Form 4). Over a trading history stretching from 10 March 2006 to 12 March 2008, the count stands at 9 filings.

Both buying and selling appear: 1 purchase worth €663, against 4 sales worth €25k. Netting one side against the other leaves €24k of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 4 share grants. So far in 2008, the count stands at no purchases and 3 sales.

The record was last updated on 13 March 2008 with an open-market sale (€5,225) in GTC Biotherapeutics Inc. The latest purchase dates back some time: it was published 6,902 days ago, on 17 December 2007. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.